MEBORESEARCH

MEBO Research, Inc., (MEBO) is a sufferer-founded patient advocacy international campaign registered in the State of Florida, U.S., since April 21, 2010, under section 501(c)(3) of the Internal Revenue Code, classification of Public Charity. MEBO Research is also registered in England and Wales as a Not For Profit, Limited by Guarantee Company (2009). MEBO is a NORD and EURORDIS Organization Member and its directors are moderators of the Trimethylaminuria Community at RareConnect.org. MEBO is referenced as an Advocacy and Support Organization in websites like the Genetic Alliance and Orphanet. MEBO is the impacted group for the MRC Research Grant of £360,684, as noted in the 'Outcomes' Tab of the Gateway to Research, Research Councils UK site... Not to be confused with the newly formed MEBO-uBiome Research grant study mentioned at the top of this page (June, 2018), MEBO is continuing the (Independent Study) "Gut Microbiome Research Study" to explore sufferers' gut microbiome; the team..

Also known as: MeBO Research UK, MeBO Research USA, MEBO Research, Inc.